Evidence map›Paper›PMID 28705221›Full record

ReviewCell communication and signaling : CCS2017

Viral manipulation of the cellular sumoylation machinery.

Angela J Lowrey, Wyatt Cramblet, Gretchen L Bentz

Open access · goldAbstract readReview
In one paragraph

Review in Cell communication and signaling : CCS, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 59 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. iScience · 2022
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. SUMO: a novel target for anti-coronavirus therapy.Pathogens and global health · 2021
    Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Angela J LowreyDivision of Biomedical Sciences, Mercer University School of Medicine, Macon, Georgia.
Wyatt CrambletDivision of Biomedical Sciences, Mercer University School of Medicine, Macon, Georgia.
Gretchen L BentzDivision of Biomedical Sciences, Mercer University School of Medicine, Macon, Georgia. bentz_GL@mercer.edu.
Mercer University · US

Funding

The Function of EBV LMP1 CTAR3 in Sumoylation and OncogenesisR00CA160786 · NCI · MERCER UNIVERSITY MACON · PI BENTZ, GRETCHEN L · 2014 to 2016
$744k
The Function of EBV LMP1 CTAR3 in Sumoylation and OncogenesisK99CA160786 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI BENTZ, GRETCHEN L · 2013 to 2013
$83k
NCI NIH HHS K99 CA160786NCI NIH HHS R00 CA160786
6 · The paper itself

Abstract

Viruses exploit various cellular processes for their own benefit, including counteracting anti-viral responses and regulating viral replication and propagation. In the past 20 years, protein sumoylation has emerged as an important post-translational modification that is manipulated by viruses to modulate anti-viral responses, viral replication, and viral pathogenesis. The process of sumoylation is a multi-step cascade where a small ubiquitin-like modifier (SUMO) is covalently attached to a conserved ΨKxD/E motif within a target protein, altering the function of the modified protein. Here we review how viruses manipulate the cellular machinery at each step of the sumoylation process to favor viral survival and pathogenesis.

Indexed as

SumoylationAnimalsHumansSmall Ubiquitin-Related Modifier ProteinsUbiquitin-Protein Ligase ComplexesVirus DiseasesSmall Ubiquitin-Related Modifier ProteinsUbiquitin-Protein Ligase ComplexesPiasRanBP2SAE1SAE2SenpSmall ubiquitin-like modifierSumoUbc9Viruses

Identifiers

PMID28705221
PMCPMC5513362
OpenAlexW2735906319

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.